ArticleFrontiers in oncology2026

HBV reactivation in HCC patients following TACE: risk factors, antiviral therapy impact, and survival analysis.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.